Related references
Note: Only part of the references are listed.Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
Duminda Suraweera et al.
GUT AND LIVER (2016)
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Luca Saverio Belli et al.
JOURNAL OF HEPATOLOGY (2016)
EASL Clinical Practice Guidelines: Liver transplantation
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2016)
Estimating average alcohol consumption in the population using multiple sources: the case of Spain
Luis Sordo et al.
POPULATION HEALTH METRICS (2016)
Patient With Decompensated Hepatitis C Virus-Related Cirrhosis Delisted for Liver Transplantation After Successful Sofosbuvir-Based Treatment
Isaac Ruiz et al.
LIVER TRANSPLANTATION (2015)
Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes
Richard M. Woodford et al.
OBESITY SURGERY (2015)
Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list
Martin Bonacci et al.
TRANSPLANT INTERNATIONAL (2015)
Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?
Nicolas Goldaracena et al.
TRANSPLANTATION DIRECT (2015)
Drinking pattern is more strongly associated with under-reporting of alcohol consumption than socio-demographic factors: evidence from a mixed-methods study
Sadie Boniface et al.
BMC PUBLIC HEALTH (2014)
Evaluation for Liver Transplantation in Adults: 2013 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Paul Martin et al.
HEPATOLOGY (2014)
Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes
Trevor W. Reichman et al.
TRANSPLANT INTERNATIONAL (2013)
All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study
Kate M. Fleming et al.
LIVER INTERNATIONAL (2012)
Liver Transplant Recipient Survival Benefit with Living Donation in the Model for Endstage Liver Disease Allocation Era
Carl L. Berg et al.
HEPATOLOGY (2011)
Live Donor Liver Transplantation in High MELD Score Recipients
Markus Selzner et al.
ANNALS OF SURGERY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis European Association for the Study of the Liver
Pere Gines et al.
JOURNAL OF HEPATOLOGY (2010)
Clinical, Virologic, Histologic, and Biochemical Outcomes After Successful HCV Therapy: A 5-Year Follow-up of 150 Patients
Sarah L. George et al.
HEPATOLOGY (2009)
Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C
Vincent Mallet et al.
ANNALS OF INTERNAL MEDICINE (2008)
Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis
Stuart Roberts et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing
S. A. Shah et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
The Model for End-stage Liver Disease (MELD)
Patrick S. Kamath et al.
HEPATOLOGY (2007)
Prevention and management of Gastroesophageal varices and variceal Hemorrhage in cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2007)
Natural history of patients hospitalized for management of cirrhotic ascites
Ramon Planas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B
N Nikolaidis et al.
CLINICAL TRANSPLANTATION (2005)
Histological outcome during long-term lamivudine therapy
JL Dienstag et al.
GASTROENTEROLOGY (2003)
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
FY Yao et al.
HEPATOLOGY (2001)
A model to predict survival in patients with end-stage liver disease
PS Kamath et al.
HEPATOLOGY (2001)
Beneficial effects lamivudine in hepatitis B virus-related decompensated cirrhosis
D Kapoor et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
